🏢 Biotech Companies

Discover biotech companies with upcoming Phase 2 & 3 catalysts

10 companies found

View:

MRNA

Moderna Inc

Market Cap: 45.0B

Industry: Biotechnology

Active Trials: 8

Upcoming Catalysts: 2

🚨 High-Impact Catalysts:

mRNA-1273

Nov 15 • Topline data

mRNA-1345

Jul 30 • Primary endpoint

View Details

GILD

Gilead Sciences Inc

Market Cap: 85.0B

Industry: Biotechnology

Active Trials: 6

Upcoming Catalysts: 0

🚨 High-Impact Catalysts:

GS-441524

Feb 28 • Primary endpoint

GS-441524

Mar 29 • Interim analysis

View Details

BIIB

Biogen Inc

Market Cap: 35.0B

Industry: Biotechnology

Active Trials: 17

Upcoming Catalysts: 4

🚨 High-Impact Catalysts:

BIIB080

Oct 30 • Primary endpoint

Felzartamab

Dec 01 • Primary endpoint

View Details

REGN

Regeneron Pharmaceuticals

Market Cap: 80.0B

Industry: Biotechnology

Active Trials: 20

Upcoming Catalysts: 2

🚨 High-Impact Catalysts:

REGN-832

Dec 25 • Interim analysis

REGN-832

Dec 20 • Topline data

View Details

VRTX

Vertex Pharmaceuticals

Market Cap: 90.0B

Industry: Biotechnology

Active Trials: 19

Upcoming Catalysts: 3

🚨 High-Impact Catalysts:

VRTX-120

Dec 03 • Primary endpoint

VRTX-120

Jan 01 • Topline data

View Details

ALNY

Alnylam Pharmaceuticals

Market Cap: 25.0B

Industry: Biotechnology

Active Trials: 4

Upcoming Catalysts: 2

🚨 High-Impact Catalysts:

ALNY-593

Nov 15 • Interim analysis

ALNY-593

Dec 18 • Primary endpoint

View Details

BMRN

BioMarin Pharmaceutical

Market Cap: 15.0B

Industry: Biotechnology

Active Trials: 3

Upcoming Catalysts: 2

🚨 High-Impact Catalysts:

BMRN-840

Oct 28 • Interim analysis

BMRN-840

Jan 16 • Interim analysis

View Details

INCY

Incyte Corporation

Market Cap: 12.0B

Industry: Biotechnology

Active Trials: 9

Upcoming Catalysts: 3

🚨 High-Impact Catalysts:

INCY-105

Dec 04 • Primary endpoint

INCY-105

Oct 25 • Interim analysis

View Details

SGEN

Seagen Inc

Market Cap: 30.0B

Industry: Biotechnology

Active Trials: 12

Upcoming Catalysts: 2

🚨 High-Impact Catalysts:

SGEN-518

Nov 12 • Primary endpoint

SGEN-518

Nov 17 • Topline data

View Details

NBIX

Neurocrine Biosciences

Market Cap: 10.0B

Industry: Biotechnology

Active Trials: 3

Upcoming Catalysts: 2

View Details